Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Preventing Heart Failure With Farxiga
Normalizing Glucose Prevents Cognitive Decline
Fractures and Diabetes in African American and Hispanic Patients
MOST POPULAR ARTICLES OF THE MONTH
#1 Could Carb Restriction Lead to Diabetes Remission?
#2 The Use of Dietary Supplements in the Treatment of Diabetes
#3 Did You Know? Metformin, along with dozens of drugs, may have promise against COVID-19
Letter from the Editor
Since February we have been looking for care solutions for our patients that have been diagnosed with the coronavirus. At first we thought it was strictly a respiratory problem and all damage was to the lungs. As time has progressed, we have seen the effect COVID-19 has had on the circulatory system, and there especially seems to be a problem with younger patients and blood clots. The desire to help prevent serious effects is leading many companies to get accelerated approval for currently used medications.
This week our intern Zahra Hashemy, PharmD. Candidate, USF Taneja College of Pharmacy, tracks the accelerated approval of a diabetes drug for reduction of death and heart failure after a heart attack.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.
Type 2 diabetes damages brain regions that govern memory, movement, and visual processing.
African Americans and Hispanics are at increased risk for many diabetes complications; are fractures among them?